Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-31
DOI
10.1038/srep23857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence for the Importance of Personalized Molecular Profiling in Pancreatic Cancer
- (2014) Loukia N. Lili et al. PANCREAS
- Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
- (2014) Paul Geeleher et al. GENOME BIOLOGY
- A new approach for prediction of tumor sensitivity to targeted drugs based on functional data
- (2013) Noah Berlow et al. BMC BIOINFORMATICS
- Comparison and validation of genomic predictors for anticancer drug sensitivity
- (2013) Simon Papillon-Cavanagh et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
- (2013) Michael P. Menden et al. PLoS One
- MEK inhibitors as a chemotherapeutic intervention in multiple myeloma
- (2013) C Chang-Yew Leow et al. Blood Cancer Journal
- Next-generation sequencing in breast cancer
- (2012) Christine Desmedt et al. CURRENT OPINION IN ONCOLOGY
- Personalized Medicine in Breast Cancer: A Systematic Review
- (2012) Sang-Hoon Cho et al. Journal of Breast Cancer
- Personalized oncology: Recent advances and future challenges
- (2012) Madhu Kalia METABOLISM-CLINICAL AND EXPERIMENTAL
- Dissecting the genomic complexity underlying medulloblastoma
- (2012) David T. W. Jones et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
- (2012) A. H. Shain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212
- (2011) J. Jing et al. MOLECULAR CANCER THERAPEUTICS
- KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials
- (2010) Aarti Garg et al. BMC BIOINFORMATICS
- Advances in understanding cancer genomes through second-generation sequencing
- (2010) Matthew Meyerson et al. NATURE REVIEWS GENETICS
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
- (2010) C. D. Klaassen et al. PHARMACOLOGICAL REVIEWS
- Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines
- (2008) Pedro P. Medina et al. HUMAN MUTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started